Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Chiorazzi

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Leukemia Research|October 27, 2009
Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: validation of a simplified method suitable for multi-center clinical studiesGregory M Hayes, Robert Busch, Jason Voogt, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2009
Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockadesXiao-Jie Yan, Mei Qi, Gloria Telusma, et al.
Blood|August 10, 2012
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patientsRajendra N Damle, Sonal Temburni, Taraneh Banapour, et al.
Haematologica|February 22, 2008
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsGiovanna Cutrona, Monica Colombo, Serena Matis, et al.
Blood|March 4, 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaFu Jun Li, Shouluan Ding, Jicun Pan, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2016
Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation statusKaterina Hatzi, Rosa Catera, Carolina Moreno Atanasio, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Blood|October 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRDEkaterina Kim, Shih-Shih Chen, Mariela Sivina, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemiaFabio Ghiotto, Franco Fais, Emilia Albesiano, et al.
Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Leukemia Research|October 27, 2009
Isolation of malignant B cells from patients with chronic lymphocytic leukemia (CLL) for analysis of cell proliferation: validation of a simplified method suitable for multi-center clinical studiesGregory M Hayes, Robert Busch, Jason Voogt, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2009
Indole-3-carbinol improves survival in lupus-prone mice by inducing tandem B- and T-cell differentiation blockadesXiao-Jie Yan, Mei Qi, Gloria Telusma, et al.
Blood|August 10, 2012
T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patientsRajendra N Damle, Sonal Temburni, Taraneh Banapour, et al.
Haematologica|February 22, 2008
Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cellsGiovanna Cutrona, Monica Colombo, Serena Matis, et al.
Blood|March 4, 2008
FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemiaFu Jun Li, Shouluan Ding, Jicun Pan, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2016
Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation statusKaterina Hatzi, Rosa Catera, Carolina Moreno Atanasio, et al.
Blood|December 20, 2011
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoSabine Ponader, Shih-Shih Chen, Joseph J Buggy, et al.
Blood|October 23, 2024
Deuterated water labeling in ibrutinib-treated patients with CLL: leukemia cell kinetics correlate with IGHV, ZAP-70, and MRDEkaterina Kim, Shih-Shih Chen, Mariela Sivina, et al.
Molecular Medicine (Cambridge, Mass.)|March 24, 2007
Similarities and differences between the light and heavy chain Ig variable region gene repertoires in chronic lymphocytic leukemiaFabio Ghiotto, Franco Fais, Emilia Albesiano, et al.
Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Pageof 17